<table border="1" class="dataframe">
  <thead>
    <tr>
      <th></th>
      <th></th>
      <th colspan="5" halign="left">Grouped by Diabetes history</th>
    </tr>
    <tr>
      <th></th>
      <th></th>
      <th>Missing</th>
      <th>Overall</th>
      <th>No Prior Diabetes</th>
      <th>Prior Diabetes</th>
      <th>P-Value</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>n</th>
      <th></th>
      <td></td>
      <td>5587</td>
      <td>399</td>
      <td>5188</td>
      <td></td>
    </tr>
    <tr>
      <th>Age, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>52.0 [43.0,60.0]</td>
      <td>49.0 [36.0,60.0]</td>
      <td>53.0 [43.0,60.0]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">Sex, n (%)</th>
      <th>Female</th>
      <td></td>
      <td>3901 (69.8)</td>
      <td>300 (75.2)</td>
      <td>3601 (69.4)</td>
      <td>0.018</td>
    </tr>
    <tr>
      <th>Male</th>
      <td></td>
      <td>1686 (30.2)</td>
      <td>99 (24.8)</td>
      <td>1587 (30.6)</td>
      <td></td>
    </tr>
    <tr>
      <th rowspan="3" valign="top">First semaglutide - brand name, n (%)</th>
      <th>Ozempic</th>
      <td></td>
      <td>4959 (88.8)</td>
      <td>300 (75.2)</td>
      <td>4659 (89.8)</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>RYBELSUS</th>
      <td></td>
      <td>574 (10.3)</td>
      <td>57 (14.3)</td>
      <td>517 (10.0)</td>
      <td></td>
    </tr>
    <tr>
      <th>WEGOVY</th>
      <td></td>
      <td>54 (1.0)</td>
      <td>42 (10.5)</td>
      <td>12 (0.2)</td>
      <td></td>
    </tr>
    <tr>
      <th rowspan="2" valign="top">First semaglutide - dosage form, n (%)</th>
      <th>INJECTION, SOLUTION</th>
      <td></td>
      <td>5013 (89.7)</td>
      <td>342 (85.7)</td>
      <td>4671 (90.0)</td>
      <td>0.008</td>
    </tr>
    <tr>
      <th>TABLET</th>
      <td></td>
      <td>574 (10.3)</td>
      <td>57 (14.3)</td>
      <td>517 (10.0)</td>
      <td></td>
    </tr>
    <tr>
      <th>First semaglutide - total payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>0.0 [0.0,720.4]</td>
      <td>2.0 [0.0,4.6]</td>
      <td>0.0 [0.0,744.1]</td>
      <td>0.043</td>
    </tr>
    <tr>
      <th>First semaglutide - out-of-pocket payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>0.0 [0.0,0.0]</td>
      <td>0.0 [0.0,4.2]</td>
      <td>0.0 [0.0,0.0]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>Average monthly total payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>196.7 [7.3,1377.4]</td>
      <td>74.8 [5.4,661.5]</td>
      <td>211.4 [8.4,1442.2]</td>
      <td>&lt;0.001</td>
    </tr>
    <tr>
      <th>Average monthly out-of-pocket payment, median [Q1,Q3]</th>
      <th></th>
      <td>0</td>
      <td>0.0 [0.0,2.3]</td>
      <td>0.5 [0.0,4.5]</td>
      <td>0.0 [0.0,2.1]</td>
      <td>&lt;0.001</td>
    </tr>
  </tbody>
</table>